About Sheikh Shakhbout Medical City
"SSMC is the future of healthcare in the Emirate of Abu Dhabi, and one of the most important developments in the medical sector in the region. As the largest tertiary hospital in the UAE, SSMC is a reflection of SEHA’s commitment to clinical excellence and superior patient experience."
Clinical Trials at Sheikh Shakhbout Medical City
During the past decade, Sheikh Shakhbout Medical City conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sheikh Shakhbout Medical City"
#1 collaborator was "Abu Dhabi University" with 1 trials as a collaborator, "Cleveland Clinic Abu Dhabi" with 1 trials as a collaborator, "Mediclinic Middle East" with 1 trials as a collaborator, "Myriad Global Solutions" with 1 trials as a collaborator and "Sheikh Khalifa Medical City" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Sheikh Shakhbout Medical City
According to Clinical.Site data, the most researched conditions in "Sheikh Shakhbout Medical City" are
"Acute Coronary Syndrome" (1 trials), "Burnout" (1 trials), "Cardiovascular Risk Factor" (1 trials), "Chest Pain" (1 trials) and "Immune Deficiency" (1 trials). Many other conditions were trialed in "Sheikh Shakhbout Medical City" in a lesser frequency.
Clinical Trials Intervention Types at Sheikh Shakhbout Medical City
Most popular intervention types in "Sheikh Shakhbout Medical City" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Application of acute chest pain risk stratification scores (HEART and EDACS)" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sheikh Shakhbout Medical City
The vast majority of trials in "Sheikh Shakhbout Medical City" are
4 trials for "All" genders.
Clinical Trials Status at Sheikh Shakhbout Medical City
Currently, there are NaN active trials in "Sheikh Shakhbout Medical City".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sheikh Shakhbout Medical City,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sheikh Shakhbout Medical City, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".